Table 2 Co-expression ratios for farnesyl diphosphate synthase (FDPS) and taste cell markers in mouse circumvallate and fungiform papillae treated with risedronate three times a week for 28 days.
Figure 3A–C | CV | FDPS/CA4 | 75.8% | (639/843, n = 245) | CA4/FDPS | 65.6% | (639/974, n = 245) |
FDPS/T1R3 | 7.90% | (27/343, n = 102) | T1R3/FDPS | 7.50% | (27/360, n = 102) | ||
FDPS/Gustducin | 10.4% | (45/433, n = 127) | Gustducin/FDPS | 9.30% | (45/485, n = 127) | ||
FP | FDPS/CA4 | 78.3% | (54/69, n = 50) | CA4/FDPS | 54.0% | (54/100, n = 50) | |
FDPS/T1R3 | 19.1% | (26/136, n = 78) | T1R3/FDPS | 16.0% | (26/163, n = 78) | ||
FDPS/Gustducin | 18.9% | (14/74, n = 61) | Gustducin/FDPS | 11.1% | (14/126, n = 61) |